These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18606668)

  • 41. Comparative quantitative mass spectrometry analysis of MHC class II-associated peptides reveals a role of GILT in formation of self-peptide repertoire.
    Bogunovic B; Srinivasan P; Ueda Y; Tomita Y; Maric M
    PLoS One; 2010 May; 5(5):e10599. PubMed ID: 20485683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon-gamma differentially regulates antigen-processing functions in distinct endocytic compartments of macrophages with constitutive expression of class II major histocompatibility complex molecules.
    Hockett RD; Cook JR; Findlay K; Harding CV
    Immunology; 1996 May; 88(1):68-75. PubMed ID: 8707353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences.
    Niazi KR; Ochoa MT; Sieling PA; Rooke NE; Peter AK; Mollahan P; Dickey M; Rabizadeh S; Rea TH; Modlin RL
    Immunology; 2007 Dec; 122(4):522-31. PubMed ID: 17635609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
    Zhou G; Ding ZC; Fu J; Levitsky HI
    J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficient delivery of T cell epitopes to APC by use of MHC class II-specific Troybodies.
    Lunde E; Western KH; Rasmussen IB; Sandlie I; Bogen B
    J Immunol; 2002 Mar; 168(5):2154-62. PubMed ID: 11859101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cutting edge: induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells Is STAT1-dependent but CIITA-independent.
    O'Donnell PW; Haque A; Klemsz MJ; Kaplan MH; Blum JS
    J Immunol; 2004 Jul; 173(2):731-5. PubMed ID: 15240658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tolerance induction via a B-cell delivered gene therapy-based protocol: optimization and role of the Ig scaffold.
    Lei TC; Su Y; Scott DW
    Cell Immunol; 2005 May; 235(1):12-20. PubMed ID: 16098495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules.
    Brazil MI; Weiss S; Stockinger B
    Eur J Immunol; 1997 Jun; 27(6):1506-14. PubMed ID: 9209504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins.
    Sanderson S; Frauwirth K; Shastri N
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7217-21. PubMed ID: 7638170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1.
    Rausch MP; Irvine KR; Antony PA; Restifo NP; Cresswell P; Hastings KT
    J Immunol; 2010 Sep; 185(5):2828-35. PubMed ID: 20668223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis.
    Hari A; Ganguly A; Mu L; Davis SP; Stenner MD; Lam R; Munro F; Namet I; Alghamdi E; Fürstenhaupt T; Dong W; Detampel P; Shen LJ; Amrein MW; Yates RM; Shi Y
    Eur J Immunol; 2015 Feb; 45(2):383-95. PubMed ID: 25378230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
    Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
    Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intracellular assembly and transport of endogenous peptide-MHC class II complexes.
    Rudensky AY; Maric M; Eastman S; Shoemaker L; DeRoos PC; Blum JS
    Immunity; 1994 Oct; 1(7):585-94. PubMed ID: 7600287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins.
    Lich JD; Elliott JF; Blum JS
    J Exp Med; 2000 May; 191(9):1513-24. PubMed ID: 10790426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
    Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
    J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The lysosomal cysteine proteases in MHC class II antigen presentation.
    Hsing LC; Rudensky AY
    Immunol Rev; 2005 Oct; 207():229-41. PubMed ID: 16181340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Macrophages present exogenous antigens by class I major histocompatibility complex molecules via a secretory pathway as a consequence of interferon-gamma activation.
    Martín-Orozco N; Isibasi A; Ortiz-Navarrete V
    Immunology; 2001 May; 103(1):41-8. PubMed ID: 11380691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.
    Zechel MA; Chaturvedi P; Lee-Chan EC; Rider BJ; Singh B
    J Immunol; 1996 Jun; 156(11):4232-9. PubMed ID: 8666792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endogenous pathway of class II presentation.
    Aichinger G; Lechler RI
    Biochem Soc Trans; 1995 Aug; 23(3):657-60. PubMed ID: 8566437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The FcgammaRIa (CD64) ligand binding chain triggers major histocompatibility complex class II antigen presentation independently of its associated FcR gamma-chain.
    van Vugt MJ; Kleijmeer MJ; Keler T; Zeelenberg I; van Dijk MA; Leusen JH; Geuze HJ; van de Winkel JG
    Blood; 1999 Jul; 94(2):808-17. PubMed ID: 10397749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.